| Denise D Wegrzynowicz, DO | |
|
6521 Steubenville Pike, Pittsburgh, PA 15205-1005 | |
| (412) 749-6920 | |
| (412) 749-6779 |
| Full Name | Denise D Wegrzynowicz |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 6521 Steubenville Pike, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033110515 | NPI | - | NPPES |
| 001830590 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS010074L (Pennsylvania) | Primary |
| 207Q00000X | Family Medicine | 1812 (West Virginia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Clair Hospital | Pittsburgh, PA | Hospital |
| Heritage Valley Sewickley | Sewickley, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Clair Medical Services Inc | 4183511553 | 151 |
News Archive
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.
Idera Pharmaceuticals, Inc. announced today that positive interim data from a Phase 1 clinical trial of IMO-2125, a Toll-like Receptor 9 (TLR9) agonist, in null responder patients with chronic hepatitis C virus (HCV) infection were presented at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL).
In the midst of the COVID-19 epidemic, contact tracing is downright buzzy, and not always in a good way.
Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types.
› Verified 1 days ago
| Entity Name | St Clair Medical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467485565 PECOS PAC ID: 4183511553 Enrollment ID: O20040301000889 |
News Archive
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.
Idera Pharmaceuticals, Inc. announced today that positive interim data from a Phase 1 clinical trial of IMO-2125, a Toll-like Receptor 9 (TLR9) agonist, in null responder patients with chronic hepatitis C virus (HCV) infection were presented at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL).
In the midst of the COVID-19 epidemic, contact tracing is downright buzzy, and not always in a good way.
Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Denise D Wegrzynowicz, DO 6521 Steubenville Pike, Pittsburgh, PA 15205-1005 Ph: (412) 749-6920 | Denise D Wegrzynowicz, DO 6521 Steubenville Pike, Pittsburgh, PA 15205-1005 Ph: (412) 749-6920 |
News Archive
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.
Idera Pharmaceuticals, Inc. announced today that positive interim data from a Phase 1 clinical trial of IMO-2125, a Toll-like Receptor 9 (TLR9) agonist, in null responder patients with chronic hepatitis C virus (HCV) infection were presented at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL).
In the midst of the COVID-19 epidemic, contact tracing is downright buzzy, and not always in a good way.
Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types.
› Verified 1 days ago
Christian Lima, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Delafield Rd, Suite 313, Pittsburgh, PA 15215 Phone: 412-781-0400 | |
Brianne Leigh Wehner, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Forbes Ave 3rd Floor Gumberg, Pittsburgh, PA 15282 Phone: 412-396-1650 | |
Gorka Murga, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2310 Jane St, Pittsburgh, PA 15203 Phone: 412-586-1755 | |
Bruce Richard Kelly, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 320 Guys Run Road, Pittsburgh, PA 15238 Phone: 412-435-0005 Fax: 412-435-0003 | |
Dr. John Joseph Danek, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 575 Coal Valley Road, Suite 502, Jefferson Regional Medical Center, Pittsburgh, PA 15236 Phone: 412-469-5983 Fax: 412-469-5946 | |
Dr. William E Chelen, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 120 Marion St., Pittsburgh, PA 15219 Phone: 412-232-3555 | |
Valerie Wislo, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7175 Saltsburg Rd, Pittsburgh, PA 15235 Phone: 412-795-7366 |